Journal of General and Molecular Virology
Subscribe to JGMV
Full Name*
Email Address*

Article Number - 5044F6611061

Vol.5(1), pp. 1-8 , May 2013

ISSN: 2141-6648

Full Length Research Paper

Rapid progression to human immunodeficiency virus infection / acquired immunodeficiency syndrome (HIV/AIDS) correlates with variation in viral ‘tat’ sequences

Mary Bridget Nanteza2, David Yirrell1,5, Benon Biryahwaho2, Natasha Larke3, Emily Webb3, Frances Gotch4 and Pontiano Kaleebu1,2


1MRC/UVRI Uganda Research Unit on AIDS, c/o Uganda Virus Research Institute, Plot 51-59 Nakiwogo Road, P. O. Box 49, Entebbe, Uganda.

2Uganda Virus Research Institute, Plot 51-59 Nakiwogo Road, P. O. Box 49, Entebbe, Uganda.

3MRC Tropical Epidemiology group, London School of Hygiene and Tropical Medicine,Keppel Street, London WC1E 7HT, United Kingdom.

4Department of Immunology, Imperial College, Chelsea and Westminster Hospital 369 Fulham Rd, London SW10 9NH, United Kingdom.

5Department of Medical Microbiology, Ninewells Hospital, Dundee, DD1 9SY United Kingdom.


 Accepted: 03 December 2012  Published: 30 May 2013

Copyright © 2013 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


Gene sequence diversity plays an important function in determining survival of micro-organisms. Pathogenicity of HIV is correlated to host as well as viral factors. We aimed to identify sequence variations in tat, nef and the membrane-proximal gp41. These genes regulate important viral functions: tat for trans-activation, nef for enhancing infectivity and the membrane-proximal gp41 for fusion which could correlate with HIV disease progression. We studied HIV sequences from ART naïve adult Ugandans. Sequence diversity was analysed for 19 rapid progressors and 22 long-term survivors, Rapid progressors were individuals who progressed to a CD4 count of <200 cells/µl in a median time of 3.7 (range 1.3 to 4.9) years. The median time is calculated as being from mid-way between the last HIV sero-negative result and the index HIV sero-positive result, to the time of obtaining the study blood sample. Long-term survivors were individuals who had a CD4 count of >500 cells/µl after a median time of 8.8 (range 7.5 to 9.3) years, measured from the time of the index HIV sero-positive result to the time of obtaining the study blood sample. Amplification of DNA by polymerase chain reaction (PCR) and subsequent sequencing of tatnef and membrane-proximal gp41 was performed starting from viral DNA directly obtained from frozen uncultured peripheral blood mononuclear cells. A ‘long’ tat protein was only observed in rapid progressors (RPs). The ‘long’ tatappears to predict rapid disease progression and could be relevant for designing an HIV-1 prognostic assay.


Key words: HIV-1, progression, tatnef, gp41.


Campbell GR, Pasquier E, Watkins J, Bourgarel-Rey V, Peyrot V, Esquieu D, Barbier P, de Mareuil J, Braguer D, Kaleebu P, Yirrell DL, Loret EP (2004). The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J. Biol. Chem. 279:48197-48204.
Chakrabarti LA, Metzner KJ, Ivanovic T, Cheng H, Louis-Virelizier J, Connor RI Cheng-Mayer C(2003). A truncated form of nef selected during pathogenic reversion of Simian Immunodeficiency Virus SIVmac239∆nef increases viral replication. J. Virol. 77:1245-1256.
PMid:12502842 PMCid:PMC140812
Churchill GA, Doerge RW (1994). Empirical threshold values for quantitative trait mapping. Genetics.138:963-971.
PMid:7851788 PMCid:PMC1206241
Felsenstein J (1993). Phylip Manual Version 3.52c. Berkeley University Herbarium, University of Calfornia Berkeley.
Geriach H, Laumann V, Martens S, Becker CF, Goody RS, Geyer M (2010). HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nat. Chem. Biol. 6:46-53.
Gupta S, Mitra D (2007). Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator. Indian J. Biochem. Biophys. 44:269-275.
Hofmann-Lehmann R, Vlasak J, Williams AL, Chenine AL, McCure HM, Anderson DC, O'Neil S, Ruprecht RM (2003). Live attenuated, nef deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS 17:157-166.
Jin YJ, Cai CY, Zhang X, Burakoff SJ(2008). Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation.J. Immunol.180:7878-7886.
Jubier-Maurin V, Saragosti S, Perret JL, Mpoudi E, Esu-Williams E, Mulanga C, Liegeois F, Ekwalanga M, Delaporte E, Peeters M(1999). Genetic characterization of the nef gene for human immuno-deficiency virus type 1: Group M strains representing genetic subtypes A, B, C, E, F, G, and H. AIDS Res. Hum. Retroviruses 15:23-32.
Kimura M (1980). A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol.16:111-120.
Kuppuswamy M, Subramanian T, Srinivasan A, Chinnadurai G (1989). Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17:3551-3561.
PMid:2542902 PMCid:PMC317795
LeGuern M, Shioda T, Levy JA, Cheng-Mayer C (1993). Single amino acid change in Tat determines the different rates of replication of two sequential HIV-1 isolates. Virology 195:441-447.
Lopez-Huertas MR, Callejas S, Abia D, Mateos E, Dopazo A, Alcami J, Coiras M (2010). Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucleic Acids Res. 38:3287-3307.
PMid:20139419 PMCid:PMC2879518
Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner HU, Mulder DW, Whitworth JA (1997). HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 350:245-250
Niyasom C, Horthongkham N, Sreephiang A, Kantakamafakul W, Louisirirofchanakuf S, Chuenchire T, Sufhent R (2009). HIV-1 subtype B Tat gene activities and disease progression in HIV-1 CRF01_AE infection. Southeast Asian J. Trop. Med. Public Health. 40:748-758.
Peloponese JM Jr, Collette Y, Gregoire C, Bailly C, Campese D, Meurs EF, Olive D, Loret EP(1999). Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J. Biol. Chem. 274:11473-11478.
Pery E, Rajendran KS, Brazier AJ, Gabuzda D (2009). Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif. J. Virol. 83:2374-2381.
PMid:19109396 PMCid:PMC2643725
Senkaali D, Kebba A, Shafer LA, Campell GR, Loret EP, Van Der Paal L, Grosskurth H, Yirrell D, Kaleebu P (2008). Tat-specific binding IgG and disease progression in HIV type 1-infected Ugandans. AIDS Res. Hum. Retroviruses 24:587-594.
Smith SM, Pentlicky S, Klase Z, Singh M, Neuveut C, Lu CY, Reitz MSJr, Yarchoan R, Marx PA, Jeang KT (2003). An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection. J. Biol. Chem. 278:44816-44825.
Sneham T, Madhavan PN Nair, Shailendra KS (2012). Rendezvous with Tat: Transactivator of Transcription during Human Immunodeficiency Virus Pathogenesis. American Journal of Infectious Diseases 8(2):79-91.
Srisurapanon S, Louisirirotchanakul S, Sumransurp K, Ratanasrithong M, Chuenchirtra T, Jintakatkom S, Wasi C (2005). Binding antibody to neutralizing epitope gp41 in HIV-1 subtype CRF 01_AE infection related to stage of disease. Southeast Asian J. Trop. Med. Public Health 36:221-227
Tzitzivacos DB, Tiemessen CT, Stevens WS, Papathanasopoulos MA (2009). Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children. AIDS Res. Hum. Retroviruses 25:1141-1148
van Baalen CA, Pontesilli O, Huisman RC, Garetti AM, Klein MR, Miedema F, Gruterset RA, Ostahaus AD(1997). Human immunodefi-ciency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J. Gen. Virol. 78:1913-1918.
Van de Peer Y, De Wachter R(1994). TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput. Appl. Biosci.10:569-570.
Walker PR, Ketunuti M, Choge IA, Meyers T, Gray G, Holmes EC, Morris L (2007). Polymorphism in nef associated with different clinical outcomes in HIV type 1 subtype C-infected children. AIDS Res. Hum. Retroviruses 23:204-215.
Zagury JF, Sill A, Blattner W, Lachgar A, Le Buanec H, Richardson M, Rappaport J, Hendel H, Bizzini B, Gringeri A, Carcagno M, Criscuolo M, Burny A, Gallo RC, Zagury D(1998). Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J. Hum. Virol. 1:282-292.


APA (2013). Rapid progression to human immunodeficiency virus infection / acquired immunodeficiency syndrome (HIV/AIDS) correlates with variation in viral ‘tat’ sequences. Journal of General and Molecular Virology, 5(1), 1-8.
Chicago Mary Bridget Nanteza, David Yirrell, Benon Biryahwaho, Natasha Larke, Emily Webb, Frances Gotch and Pontiano Kaleebu,. "Rapid progression to human immunodeficiency virus infection / acquired immunodeficiency syndrome (HIV/AIDS) correlates with variation in viral ‘tat’ sequences." Journal of General and Molecular Virology 5, no. 1 (2013): 1-8.
MLA Mary Bridget Nanteza, et al. "Rapid progression to human immunodeficiency virus infection / acquired immunodeficiency syndrome (HIV/AIDS) correlates with variation in viral ‘tat’ sequences." Journal of General and Molecular Virology 5.1 (2013): 1-8.

Subscription Form